News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
798,319 Results
Type
Article (78854)
Company Profile (490)
Press Release (718975)
Section
Business (223691)
Career Advice (3402)
Deals (38591)
Drug Delivery (121)
Drug Development (89288)
Employer Resources (187)
FDA (17580)
Job Trends (16768)
News (381897)
Policy (37813)
Tag
Academia (2965)
Alliances (54560)
Alzheimer's disease (1372)
Approvals (17516)
Artificial intelligence (173)
Bankruptcy (388)
Best Places to Work (12502)
Biotechnology (338)
Breast cancer (201)
Cancer (1490)
Cardiovascular disease (126)
Career advice (2884)
CAR-T (114)
Cell therapy (324)
Clinical research (70943)
Collaboration (530)
Compensation (279)
COVID-19 (2814)
C-suite (122)
Data (1435)
Diabetes (197)
Diagnostics (6647)
Earnings (90704)
Employer resources (163)
Events (122261)
Executive appointments (425)
FDA (18312)
Funding (470)
Gene therapy (226)
GLP-1 (722)
Government (4975)
Healthcare (20677)
Infectious disease (2916)
Inflammatory bowel disease (126)
Interviews (633)
IPO (17413)
Job creations (4715)
Job search strategy (2385)
Layoffs (494)
Legal (9444)
Lung cancer (222)
Manufacturing (235)
Medical device (14424)
Medtech (14429)
Mergers & acquisitions (21351)
Metabolic disorders (538)
Neuroscience (1733)
NextGen Class of 2024 (7499)
Non-profit (5056)
Northern California (1766)
Obesity (306)
Opinion (249)
Patents (132)
People (62532)
Phase I (21866)
Phase II (30880)
Phase III (23259)
Pipeline (534)
Postmarket research (3381)
Preclinical (9772)
Radiopharmaceuticals (257)
Rare diseases (295)
Real estate (6932)
Regulatory (25017)
Research institute (2631)
Resumes & cover letters (543)
Southern California (1523)
Startups (4170)
United States (16319)
Vaccines (667)
Weight loss (240)
Date
Last 7 days (185)
Last 30 days (1699)
Last 365 days (36782)
2025 (104)
2024 (37561)
2023 (42454)
2022 (53784)
2021 (58559)
2020 (57504)
2019 (51102)
2018 (38892)
2017 (36473)
2016 (37024)
2015 (42860)
2014 (37298)
2013 (34660)
2012 (36198)
2011 (36235)
2010 (35731)
Location
Africa (1117)
Arizona (222)
Asia (46381)
Australia (8068)
California (4036)
Canada (1493)
China (341)
Colorado (183)
Connecticut (200)
Europe (105860)
Florida (564)
Georgia (145)
Illinois (449)
Indiana (244)
Maryland (692)
Massachusetts (3200)
Michigan (183)
Minnesota (314)
New Jersey (1175)
New York (1146)
North Carolina (867)
Northern California (1766)
Ohio (153)
Pennsylvania (967)
South America (1499)
Southern California (1523)
Texas (594)
Utah (116)
Washington State (426)
798,319 Results for "st jude medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
BioLineRx Announces Clinical Trial Agreement with St. Jude Children’s Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
BioLineRx Ltd. today announced a multi-center Phase 1 clinical trial sponsored by St. Jude Children’s Research Hospital, Inc. to evaluate motixafortide for the mobilization of CD34+ hematopoietic stem cells (HSCs) used in the development of gene therapies for patients with sickle cell disease (SCD).
May 30, 2024
·
8 min read
Drug Development
CalciMedica Collaborator St. Jude Children’s Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition
CalciMedica Inc. today announced that its collaborator, St. Jude Children’s Research Hospital (SJCRH), presented data from the initial cohort of the Phase 1/2 CRSPA study of Auxora™ (zegocractin injectable emulsion) in asparaginase-induced pancreatic toxicity (AIPT).
December 11, 2023
·
9 min read
Press Releases
New Research from Children’s Hospital of Philadelphia and St. Jude Poised to Transform Approach to Diagnosing and Treating Acute Leukemia in Children
August 15, 2024
·
7 min read
Press Releases
Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event
November 12, 2024
·
1 min read
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
Xtant Medical Holdings, Inc. today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29 in Minneapolis.
May 22, 2024
·
1 min read
BioMidwest
Aatru Medical Awarded 1st Place in “Oral Abstracts” at SAWC Spring 2024 Symposium
Aatru Medical, LLC announced that it was awarded 1st Place in Oral Abstracts at the 2024 Spring symposium hosted by the Society for Advanced Wound Care (SAWC).
June 3, 2024
·
2 min read
Business
Seismic Therapeutic Appoints Brendan St. Amant as General Counsel
Seismic Therapeutic, Inc today announced the appointment of Brendan St. Amant as General Counsel and a member of the company’s leadership team.
June 25, 2024
·
2 min read
Press Releases
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter
December 5, 2024
·
2 min read
Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024
Fresenius Medical Care today announced the presentation of nearly 40 company-affiliated research abstracts at the 61st European Renal Association (ERA) Congress, taking place May 23-26, 2024, in Stockholm, Sweden and virtually.
May 21, 2024
·
5 min read
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
1 of 79,832
Next
